Form 4 for BNTC Benitec Biopharma Inc.

Accepted 2024-11-21 00:00:00 ET · period of report 2024-11-19 · accession 0000899140-24-001299 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-11-21	2024-11-19+	BNTC	Averill Master Fund, Ltd.	Dir, 10%	P - Purchase	$10.05	+41.4K	7.90M	+0.5%	+$416.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock, par value $0.0001 per share	2024-11-20	P	A	3,076	$10.22	950,314	I See footnotes	—	—	(F5) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
2	Common	Common stock, par value $0.0001 per share	2024-11-20	P	A	24,360	$10.22	7,920,175	I See footnotes	—	—	(F4) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
3	Common	Common stock, par value $0.0001 per share	2024-11-19	P	A	1,570	$9.73	947,238	I See footnotes	—	—	(F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
4	Common	Common stock, par value $0.0001 per share	2024-11-19	P	A	12,430	$9.73	7,895,815	I See footnotes	—	—	(F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.